Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alessia Biolchi, Sara Tomei, Laura Santini, Jo Anne Welsch, Daniela Toneatto, Nikolaos Gaitatzis, Xilian Bai, Ray Borrow, Marzia Monica Giuliani, Elena Mori & Mariagrazia Pizza. (2019) Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules. Human Vaccines & Immunotherapeutics 15:3, pages 725-731.
Read now
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Read now
Daniela Toneatto, Mariagrazia Pizza, Vega Masignani & Rino Rappuoli. (2017) Emerging experience with meningococcal serogroup B protein vaccines. Expert Review of Vaccines 16:5, pages 433-451.
Read now
Read now
Articles from other publishers (11)
Alessia Biolchi, Gabriella De Angelis, Monica Moschioni, Sara Tomei, Brunella Brunelli, Maria Giuliani, Stefania Bambini, Ray Borrow, Heike Claus, Maria Cecilia O. Gorla, Eva Hong, Ana Paula S. Lemos, Jay Lucidarme, Muhamed-Kheir Taha, Ulrich Vogel, Maurizio Comanducci, Sonia Budroni, Marzia M. Giuliani, Rino Rappuoli, Mariagrazia Pizza & Philip Boucher. (2020) Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates. Vaccine 38:47, pages 7542-7550.
Crossref
Crossref
Xilian Bai, Ray Borrow, Suzana Bukovski, Dominique A. Caugant, Davor Culic, Snezana Delic, Ener Cagri Dinleyici, Medeia Eloshvili, Tímea Erdősi, Jelena Galajeva, Pavla Křížová, Jay Lucidarme, Konstantin Mironov, Zuridin Nurmatov, Marina Pana, Erkin Rahimov, Larisa Savrasova, Anna Skoczyńska, Vinny Smith, Muhamed-Kheir Taha, Leonid Titov, Julio Vázquez & Lyazzat Yeraliyeva. (2019) Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe. Journal of Infection 79:6, pages 528-541.
Crossref
Crossref
Peter Piot, Heidi J. Larson, Katherine L. O’Brien, John N’kengasong, Edmond Ng, Samba Sow & Beate Kampmann. (2019) Immunization: vital progress, unfinished agenda. Nature 575:7781, pages 119-129.
Crossref
Crossref
Alastair McAlpine & Manish Sadarangani. (2019) Meningitis vaccines in children. Current Opinion in Infectious Diseases 32:5, pages 510-516.
Crossref
Crossref
Alessandro Muzzi, Alessandro Brozzi, Laura Serino, Margherita Bodini, Raquel Abad, Dominique Caugant, Maurizio Comanducci, Ana Paula Lemos, Maria Cecilia Gorla, Pavla Křížová, Claudia Mikula, Robert Mulhall, Michael Nissen, Hanna Nohynek, Maria João Simões, Anna Skoczyńska, Paola Stefanelli, Muhamed-Kheir Taha, Maija Toropainen, Georgina Tzanakaki, Kumaran Vadivelu-Pechai, Philip Watson, Julio A. Vazquez, Gowrisankar Rajam, Rino Rappuoli, Ray Borrow & Duccio Medini. (2019) Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide. Vaccine 37:7, pages 991-1000.
Crossref
Crossref
Maria Elena Flacco, Lamberto Manzoli, Annalisa Rosso, Carolina Marzuillo, Mauro Bergamini, Armando Stefanati, Rosario Cultrera, Paolo Villari, Walter Ricciardi, John P A Ioannidis & Despina G Contopoulos-Ioannidis. (2018) Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. The Lancet Infectious Diseases 18:4, pages 461-472.
Crossref
Crossref
Federico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, Pilar Infante Marquez, Josep-Lluis Arimany, Francisco Gimenez-Sanchez, José Antonio Couceiro Gianzo, Éva Kovács, Pablo Rojo, Huajun Wang, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Antibody persistence and booster responses 24–36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial. Journal of Infection 76:3, pages 258-269.
Crossref
Crossref
Raquel Abad & Julio Vazquez. (2017) Should we continue to monitor 4CMenB coverage with MATS?. The Lancet Infectious Diseases 17:7, pages 681-683.
Crossref
Crossref
Federico Martinón-Torres, Marco Aurelio P. Safadi, Alfonso Carmona Martinez, Pilar Infante Marquez, Juan Carlos Tejedor Torres, Lily Yin Weckx, Edson Duarte MoreiraJuniorJunior, Ilhem Mensi, Marco Calabresi & Daniela Toneatto. (2017) Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial. Vaccine 35:28, pages 3548-3557.
Crossref
Crossref
Jamie Findlow & Ray Borrow. (2017) Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?. Pathogens and Disease 75:2.
Crossref
Crossref
Lydiane Agier, Nadège Martiny, Oumy Thiongane, Judith E. Mueller, Juliette Paireau, Eleanor R. Watkins, Tom J. Irving, Thibaut Koutangni & Hélène Broutin. (2017) Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overview. International Journal of Infectious Diseases 54, pages 103-112.
Crossref
Crossref